Breakthroughs in Diagnosing Colorectal Cancer with Rare Genetic Variants
A new study emphasizes the potential of advanced sequencing techniques in improving outcomes for CRC patients with rare genetic variants.
Category: Colorectal
Colorectal
Latest
Colorectal
Latest
Some Patients Repeat Fecal Tests to Delay Colonoscopy
A new study found that 7.4% of patients repeated fecal testing rather than proceeding directly to colonoscopy as guidelines recommend.
Colorectal
Latest
Next-Gen Stool DNA Test for Colorectal Cancer Has High Detection Rate
Researchers say the test has the best performance for the detection of both colorectal cancer and advanced precancerous polyps.
Strategic Collaboration Aims to Bring Advanced Colorectal Cancer Screening to U.S.
Universal DX has announced a strategic collaboration with Quest Diagnostics to improve colorectal cancer screening in the United States.
Read More
Geneoscopy and Labcorp Partner to Distribute Noninvasive Colorectal Cancer Test
Geneoscopy’s multi-target stool RNA (mt-sRNA) biomarker panel is designed to detect precancerous lesions and colorectal cancer.
Read More
AI Tool Outperforms Other Colorectal Cancer Analysis Methods
Researchers have developed an artificial intelligence (AI) tool for automatic colorectal cancer tissue analysis.Â
Read More
Liquid Biopsy May Guide Colon Cancer Adjuvant TreatmentÂ
Liquid biopsy may be used to improve the response to standard chemotherapy regimens in patients with stage III or stage II colon cancer.
Read More
Colorectal Cancer: A New At-Home Test Increases Diagnostic Accuracy
The ColoAlert test is designed as a complement to colonoscopies and is designed to help detect colorectal cancer early.
Read More
New Gene Markers Detect Lynch Syndrome-Associated Colorectal Cancer
Researchers have discovered new genetic markers to identify Lynch syndrome-associated colorectal cancer with high accuracy.Â
Read More
Mainz Biomed’s Novel mRNA Biomarkers for Colorectal Cancer Achieve High Sensitivity, Specificity
Multiple novel mRNA biomarkers were identified for potential integration into pivotal FDA premarket approval clinical trial.
Read More
Proscia, DoMore Diagnostics Partner for Improved Colorectal Cancer Treatment
Proscia has partnered with DoMore Diagnostics to help pathologists predict outcomes for colorectal cancer (CRC) patients.
Read More
CVS Health to Sell Biomerica’s Colorectal Disease Test in Stores
CVS Pharmacy has begun in-store sales rollout of Biomerica’s EZ Detect colorectal disease screening test in over 7,000 stores nationwide.
Read More
ACP Updates Colorectal Cancer Screening Guidance for Asymptomatic Adults
The ACP issued new guidance for colorectal cancer screening for asymptomatic, average-risk adults that suggests starting screening at age 50.Â
Read More
Devyser Debuts 2 Genetic Test Kits for Hereditary Cancer
Devyser LynchFAP and Devyser BRCA PALB2 genetic test kits offer efficient, targeted analysis of genes associated with increased cancer risk.
Read More
Next-Gen Cologuard Test Demonstrates High Sensitivity, Specificity
BLUE-C study results show that next-generation Cologuard met all study endpoints and improved every top-line metric, including a 30% lower false positive rate.
Read More
Rideshare Can Remove Barrier to Colorectal Cancer Screening
If given a way to get home from a colonoscopy after sedation, many patients will seek out a procedure they would otherwise avoid.
Read More
New Colon MSI AI-Based Digital Assay Reduces Diagnostic TAT
Paige Colon MSI operates on whole slide images of hematoxylin and eosin (H&E)-stained slides alone, offering slide-level classification of MSI status in colon cancer samples based on morphologies associated with the presence or absence of MSI/MMR phenotype.
Read More
Double Testing More Effective for Identifying Colorectal Cancer
In addition to reducing the risk of a missed diagnosis, experts say this double testing approach has the potential to reduce demand for colonoscopies in a healthcare system under pressure.
Read More